IBDEI2X9 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46613,0)
;;=96401^^178^2322^10^^^^1
;;^UTILITY(U,$J,358.3,46613,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46613,1,2,0)
;;=2^96401
;;^UTILITY(U,$J,358.3,46613,1,3,0)
;;=3^Chemotherapy,IM/SQ
;;^UTILITY(U,$J,358.3,46614,0)
;;=96402^^178^2322^18^^^^1
;;^UTILITY(U,$J,358.3,46614,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46614,1,2,0)
;;=2^96402
;;^UTILITY(U,$J,358.3,46614,1,3,0)
;;=3^Injec,IM,anti-neplastic horm
;;^UTILITY(U,$J,358.3,46615,0)
;;=96372^^178^2322^1^^^^1
;;^UTILITY(U,$J,358.3,46615,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46615,1,2,0)
;;=2^96372
;;^UTILITY(U,$J,358.3,46615,1,3,0)
;;=3^Administration of Inj, SC/IM
;;^UTILITY(U,$J,358.3,46616,0)
;;=96374^^178^2322^17^^^^1
;;^UTILITY(U,$J,358.3,46616,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46616,1,2,0)
;;=2^96374
;;^UTILITY(U,$J,358.3,46616,1,3,0)
;;=3^IV Push,Single Non-Chemo Drug
;;^UTILITY(U,$J,358.3,46617,0)
;;=J0897^^178^2322^14^^^^1
;;^UTILITY(U,$J,358.3,46617,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46617,1,2,0)
;;=2^J0897
;;^UTILITY(U,$J,358.3,46617,1,3,0)
;;=3^Denosumab Inj 1 mg
;;^UTILITY(U,$J,358.3,46618,0)
;;=J1950^^178^2322^23^^^^1
;;^UTILITY(U,$J,358.3,46618,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46618,1,2,0)
;;=2^J1950
;;^UTILITY(U,$J,358.3,46618,1,3,0)
;;=3^Leuprolide Acetate Susp 3.75 mg
;;^UTILITY(U,$J,358.3,46619,0)
;;=J3489^^178^2322^34^^^^1
;;^UTILITY(U,$J,358.3,46619,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46619,1,2,0)
;;=2^J3489
;;^UTILITY(U,$J,358.3,46619,1,3,0)
;;=3^Zoledronic Acid 1 mg
;;^UTILITY(U,$J,358.3,46620,0)
;;=J3490^^178^2322^30^^^^1
;;^UTILITY(U,$J,358.3,46620,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46620,1,2,0)
;;=2^J3490
;;^UTILITY(U,$J,358.3,46620,1,3,0)
;;=3^Unclassified Biologics
;;^UTILITY(U,$J,358.3,46621,0)
;;=J9155^^178^2322^13^^^^1
;;^UTILITY(U,$J,358.3,46621,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46621,1,2,0)
;;=2^J9155
;;^UTILITY(U,$J,358.3,46621,1,3,0)
;;=3^Degarelix 1 mg
;;^UTILITY(U,$J,358.3,46622,0)
;;=J9218^^178^2322^21^^^^1
;;^UTILITY(U,$J,358.3,46622,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46622,1,2,0)
;;=2^J9218
;;^UTILITY(U,$J,358.3,46622,1,3,0)
;;=3^Leuprolide (Lupron) 1mg
;;^UTILITY(U,$J,358.3,46623,0)
;;=J9219^^178^2322^22^^^^1
;;^UTILITY(U,$J,358.3,46623,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46623,1,2,0)
;;=2^J9219
;;^UTILITY(U,$J,358.3,46623,1,3,0)
;;=3^Leuprolide Acetate Implant 65 mg
;;^UTILITY(U,$J,358.3,46624,0)
;;=J0270^^178^2322^2^^^^1
;;^UTILITY(U,$J,358.3,46624,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46624,1,2,0)
;;=2^J0270
;;^UTILITY(U,$J,358.3,46624,1,3,0)
;;=3^Alprostadil 1.25 mcg
;;^UTILITY(U,$J,358.3,46625,0)
;;=J0275^^178^2322^3^^^^1
;;^UTILITY(U,$J,358.3,46625,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46625,1,2,0)
;;=2^J0275
;;^UTILITY(U,$J,358.3,46625,1,3,0)
;;=3^Alprostadil Urethral Suppository
;;^UTILITY(U,$J,358.3,46626,0)
;;=J2370^^178^2322^27^^^^1
;;^UTILITY(U,$J,358.3,46626,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46626,1,2,0)
;;=2^J2370
;;^UTILITY(U,$J,358.3,46626,1,3,0)
;;=3^Phenyleprhine HCL 1 mg
;;^UTILITY(U,$J,358.3,46627,0)
;;=J1212^^178^2322^11^^^^1
;;^UTILITY(U,$J,358.3,46627,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,46627,1,2,0)
;;=2^J1212
;;^UTILITY(U,$J,358.3,46627,1,3,0)
;;=3^DMSO per 50 ml
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2X9 3769 printed Dec 13, 2024@02:37:36 Page 2
IBDEI2X9 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46613,0)
+2 ;;=96401^^178^2322^10^^^^1
+3 ;;^UTILITY(U,$J,358.3,46613,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,46613,1,2,0)
+6 ;;=2^96401
+7 ;;^UTILITY(U,$J,358.3,46613,1,3,0)
+8 ;;=3^Chemotherapy,IM/SQ
+9 ;;^UTILITY(U,$J,358.3,46614,0)
+10 ;;=96402^^178^2322^18^^^^1
+11 ;;^UTILITY(U,$J,358.3,46614,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,46614,1,2,0)
+14 ;;=2^96402
+15 ;;^UTILITY(U,$J,358.3,46614,1,3,0)
+16 ;;=3^Injec,IM,anti-neplastic horm
+17 ;;^UTILITY(U,$J,358.3,46615,0)
+18 ;;=96372^^178^2322^1^^^^1
+19 ;;^UTILITY(U,$J,358.3,46615,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,46615,1,2,0)
+22 ;;=2^96372
+23 ;;^UTILITY(U,$J,358.3,46615,1,3,0)
+24 ;;=3^Administration of Inj, SC/IM
+25 ;;^UTILITY(U,$J,358.3,46616,0)
+26 ;;=96374^^178^2322^17^^^^1
+27 ;;^UTILITY(U,$J,358.3,46616,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,46616,1,2,0)
+30 ;;=2^96374
+31 ;;^UTILITY(U,$J,358.3,46616,1,3,0)
+32 ;;=3^IV Push,Single Non-Chemo Drug
+33 ;;^UTILITY(U,$J,358.3,46617,0)
+34 ;;=J0897^^178^2322^14^^^^1
+35 ;;^UTILITY(U,$J,358.3,46617,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,46617,1,2,0)
+38 ;;=2^J0897
+39 ;;^UTILITY(U,$J,358.3,46617,1,3,0)
+40 ;;=3^Denosumab Inj 1 mg
+41 ;;^UTILITY(U,$J,358.3,46618,0)
+42 ;;=J1950^^178^2322^23^^^^1
+43 ;;^UTILITY(U,$J,358.3,46618,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,46618,1,2,0)
+46 ;;=2^J1950
+47 ;;^UTILITY(U,$J,358.3,46618,1,3,0)
+48 ;;=3^Leuprolide Acetate Susp 3.75 mg
+49 ;;^UTILITY(U,$J,358.3,46619,0)
+50 ;;=J3489^^178^2322^34^^^^1
+51 ;;^UTILITY(U,$J,358.3,46619,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,46619,1,2,0)
+54 ;;=2^J3489
+55 ;;^UTILITY(U,$J,358.3,46619,1,3,0)
+56 ;;=3^Zoledronic Acid 1 mg
+57 ;;^UTILITY(U,$J,358.3,46620,0)
+58 ;;=J3490^^178^2322^30^^^^1
+59 ;;^UTILITY(U,$J,358.3,46620,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,46620,1,2,0)
+62 ;;=2^J3490
+63 ;;^UTILITY(U,$J,358.3,46620,1,3,0)
+64 ;;=3^Unclassified Biologics
+65 ;;^UTILITY(U,$J,358.3,46621,0)
+66 ;;=J9155^^178^2322^13^^^^1
+67 ;;^UTILITY(U,$J,358.3,46621,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,46621,1,2,0)
+70 ;;=2^J9155
+71 ;;^UTILITY(U,$J,358.3,46621,1,3,0)
+72 ;;=3^Degarelix 1 mg
+73 ;;^UTILITY(U,$J,358.3,46622,0)
+74 ;;=J9218^^178^2322^21^^^^1
+75 ;;^UTILITY(U,$J,358.3,46622,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,46622,1,2,0)
+78 ;;=2^J9218
+79 ;;^UTILITY(U,$J,358.3,46622,1,3,0)
+80 ;;=3^Leuprolide (Lupron) 1mg
+81 ;;^UTILITY(U,$J,358.3,46623,0)
+82 ;;=J9219^^178^2322^22^^^^1
+83 ;;^UTILITY(U,$J,358.3,46623,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,46623,1,2,0)
+86 ;;=2^J9219
+87 ;;^UTILITY(U,$J,358.3,46623,1,3,0)
+88 ;;=3^Leuprolide Acetate Implant 65 mg
+89 ;;^UTILITY(U,$J,358.3,46624,0)
+90 ;;=J0270^^178^2322^2^^^^1
+91 ;;^UTILITY(U,$J,358.3,46624,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,46624,1,2,0)
+94 ;;=2^J0270
+95 ;;^UTILITY(U,$J,358.3,46624,1,3,0)
+96 ;;=3^Alprostadil 1.25 mcg
+97 ;;^UTILITY(U,$J,358.3,46625,0)
+98 ;;=J0275^^178^2322^3^^^^1
+99 ;;^UTILITY(U,$J,358.3,46625,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,46625,1,2,0)
+102 ;;=2^J0275
+103 ;;^UTILITY(U,$J,358.3,46625,1,3,0)
+104 ;;=3^Alprostadil Urethral Suppository
+105 ;;^UTILITY(U,$J,358.3,46626,0)
+106 ;;=J2370^^178^2322^27^^^^1
+107 ;;^UTILITY(U,$J,358.3,46626,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,46626,1,2,0)
+110 ;;=2^J2370
+111 ;;^UTILITY(U,$J,358.3,46626,1,3,0)
+112 ;;=3^Phenyleprhine HCL 1 mg
+113 ;;^UTILITY(U,$J,358.3,46627,0)
+114 ;;=J1212^^178^2322^11^^^^1
+115 ;;^UTILITY(U,$J,358.3,46627,1,0)
+116 ;;=^358.31IA^3^2
+117 ;;^UTILITY(U,$J,358.3,46627,1,2,0)
+118 ;;=2^J1212
+119 ;;^UTILITY(U,$J,358.3,46627,1,3,0)
+120 ;;=3^DMSO per 50 ml
